Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Ventricular assist device Stories

2011-12-16 10:59:00

HOUSTON, Dec. 16, 2011 /PRNewswire/ -- Newborns, toddlers and teens who suffer from heart failure and need heart transplantation to survive just got a life-saving pediatric heart pump that buys time and allows them to grow stronger as they wait for a donor heart. To view the multimedia assets associated with this release, please click...

2011-12-12 09:00:00

LA JOLLA, Calif., Dec. 12, 2011 /PRNewswire/ -- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that its investigational product candidate MYDICAR® has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of advanced heart failure. The Fast Track program of the FDA is designed to facilitate the development and...

2011-12-09 10:00:00

PLEASANTON, Calif., Dec. 9, 2011 /PRNewswire/ -- Thoratec (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Oppenheimer & Co. 22nd Annual Healthcare Conference on Tuesday, December 13. Taylor C. Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company, beginning at 10:15 a.m., Eastern Standard Time...

2011-12-09 09:36:00

FRAMINGHAM, Mass. and SYDNEY, Dec. 9, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Oppenheimer 22nd Annual Healthcare Conference at 10:50 a.m. EST on Wednesday, December 14, 2011. The conference is being held December 13-14, 2011 at...

2011-12-08 19:45:00

ATLANTA, Dec. 8, 2011 /PRNewswire/ -- CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes. While the panel agreed that the CardioMEMS technology is safe with a vote of 9-1, the majority did not vote positively that the System...

2011-11-23 07:30:00

PLEASANTON, Calif., Nov. 23, 2011 /PRNewswire/ -- Thoratec (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Tuesday, November 29, the company will participate in the Piper Jaffray 23(rd) Annual Health Care Conference. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the...

2011-11-23 05:00:00

FRAMINGHAM, Mass. and SYDNEY, Nov. 23, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 23(rd) Annual Piper Jaffray Health Care Conference at 11:30 a.m. EST on Wednesday, November 30, 2011. The conference is being held November 29-30,...

2011-11-14 15:43:00

ORLANDO, Florida and MELBOURNE, Australia, November 14, 2011 /PRNewswire/ -- - Revascor(TM), Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe and well-tolerated at all doses, with no clinically relevant immune responses to donor cells - Revascor(TM) therapy significantly reduced cardiac mortality and major adverse cardiac events (MACE) in patients with congestive...

2011-11-10 13:10:00

VCU Medical Centerâs Retrospective Study Compares Patient Exercise Performance and Blood Pressure Response of the Total Artificial Heart vs. the HeartMate II LVAD Tucson, AZ (PRWEB) November 10, 2011 In the November issue of The Journal of Heart and Lung Transplantation (JHLT), Virginia Commonwealth University (VCU) Medical Center in Richmond published the first findings demonstrating that physical exercise and measurable rehabilitation are feasible with the SynCardia temporary...

2011-11-10 05:00:00

FRAMINGHAM, Mass. and SYDNEY, Nov. 10, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Lazard Capital Markets 8th Annual Healthcare Conference at 1:30 p.m. EST on Wednesday, November 16, 2011. The conference is being held November 15-16, 2011...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »